1. Home
  2. |Insights
  3. |Crowell & Moring Named Finalist in Global Competition Review's Fourth Annual "GCR Awards"

Crowell & Moring Named Finalist in Global Competition Review's Fourth Annual "GCR Awards"

Firm News | 1 min read | 04.08.14

Washington, D.C. – April 8, 2014: Global Competition Review (GCR), considered to be the leading international journal of competition policy and regulation, selected two matters handled by Crowell & Moring LLP as finalists for the fourth annual "GCR Awards." Specifically the matters include, Aetna Inc.'s acquisition of Coventry Health Care, Inc., which was named as one of five finalists in the "Team Awards: Merger Control Matter of the Year – Americas" category. Crowell & Moring served as U.S. antitrust counsel to Coventry Health Care, Inc. in this deal. In addition, the Freight Fuel Surcharge Antitrust Litigation before the U.S. Court of Appeals for the District of Columbia was selected as one of six finalists in the "Team Awards: Litigation of the Year" category. Crowell & Moring serves as lead trial counsel to CSX Transportation, Inc. in this matter.

The "GCR Awards" were presented during the annual dinner held in the events honor at the W Hotel in Washington, D.C. on March 25. According to Global Competition Review, the "GCR Awards" aim to recognize the achievements of teams and individuals from private practice firms, corporate legal departments, economic consultancies, academic organizations, and competition authorities in 2013. Finalists were initially compiled by a GCR editorial team at the publication and winners were selected through online voting.

Also of note, Crowell & Moring's Antitrust Group continues to be recognized as "Highly Recommended" in the annual "GCR 100: The World's Leading Competition Practices," in the categories of "United States: Government Antitrust" and "United States: New York." 

Crowell & Moring LLP is an international law firm with more than 500 lawyers representing clients in litigation and arbitration, regulatory, and transactional matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation, as well as its ongoing commitment to pro bono service and diversity. The firm has offices in Washington, D.C., New York, Los Angeles, San Francisco, Orange County, Anchorage, London, and Brussels.

Insights

Firm News | 1 min read | 03.11.25

Crowell & Moring Represents Nuclear Energy Startup Atomic Alchemy in its Acquisition by Oklo

March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn....

View All Insights